NAI IL-15sa

Interleukin-15 superagonist

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for NAI IL-15sa, covering 2026-02-27 to 2026-02-27. Get the full timeline:

Most recent: Clinical Trial Update: PD-L1 t-haNK, NAI IL-15sa and Cetuximab for Recurrent, Metastatic HNSCC [Phase 2]